Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Amber Meskens

Faculty of Pharmaceutical Sciences > Department of Pharmaceutical analysis

ORCID iD: 0009-0000-0201-114X

Add to list
- Conference Paper
- C3
- open access
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Gabriële Holtappels (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Sara Neyt (UGent) , et al.

(2025) 38th Annual Congress of the European Association of Nuclear Medicine - Abstracts. In EANM Innovation 1. p.s238-s239
Add to list
Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Christian Vanhove (UGent) and Jens Debacker (UGent)

(2025) Book of Abstracts - 49th European Radiation Research Society Meeting.
Add to list
- Conference Paper
- C3
Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice

Amber Meskens (UGent) , Sara Neyt (UGent) , Michaël Henrotte (UGent) , Jens Debacker (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2025) EMIM 2025 : European Molecular Imaging Meeting : 20th Annual Meeting of the European Society for Molecular Imaging, Abstracts.